2025年全球寡核苷酸合成市场报告

寡核苷酸合成市场预计将在未来几年快速成长，到2029年将达到222亿美元，复合年增长率为16.8%。预测期内的成长可归因于新型诊断工具、 RNA干扰(RNAi) 疗法、再生医学、奈米技术应用和基因编辑的进步。预测期内的主要趋势包括标靶药物开发、创新递送系统、自动化合成、CRISPR-Cas技术和次世代定序(NGS)。

未来五年16.8%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的生物技术研究，因为这会增加从日本和瑞士进口的亚磷酰胺试剂和去氧核糖核酸(DNA) 合成仪的成本，从而可能减缓药物开发并增加临床前研究成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也可能更为广泛。

寡核苷酸合成市场的成长预测预计将受到慢性病盛行率上升的推动。慢性病的特征是病程超过一年且需要持续治疗，是全球性的健康问题。寡核苷酸透过各种机制影响基因表现，在治疗慢性病方面发挥关键作用。寡核苷酸可以针对mRNA、前mRNA或非编码RNA，进而调节剪接事件、诱导降解或破坏蛋白质翻译。例如，根据国际糖尿病联盟2022年1月的报告，预计到2045年，全球糖尿病盛行率将增加12.2%，达到5.366亿20-79岁的人。此外，根据世界卫生组织（WHO）2022年9月的数据，包括心血管疾病、癌症、慢性呼吸系统疾病和糖尿病在内的慢性疾病占全球非传染性疾病相关死亡的很大一部分（74%），每年导致4,100万人死亡。此类慢性和罕见疾病的盛行率不断上升是推动寡核苷酸合成市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球寡核苷酸合成：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球寡核苷酸合成市场：成长率分析
• 全球寡核苷酸合成市场表现：规模与成长，2019-2024
• 全球寡核苷酸合成市场预测：规模与成长，2024-2029年，2034年
• 全球寡核苷酸合成：总目标市场（TAM）

第六章 市场细分

• 全球寡核苷酸合成市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 客製化寡核苷酸
• 预先设计的寡核苷酸
• 全球寡核苷酸合成市场：依产品类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 寡核苷酸
• 试剂
• 装置
• 服务
• 纯化
• 修復
• 全球寡核苷酸合成市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 治疗应用
• 研究应用
• 诊断应用
• 全球寡核苷酸合成市场：细分：客製化寡核苷酸（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 长寡核苷酸
• 短寡核苷酸
• 修饰寡核苷酸
• 全球寡核苷酸合成市场：依预设计寡核苷酸（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 基因特异性寡核苷酸
• 探针寡核苷酸
• PCR 和 RT-PCR 引子

第七章 区域和国家分析

• 全球寡核苷酸合成市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
• 全球寡核苷酸合成市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 寡核苷酸合成市场：竞争格局
• 寡核苷酸合成市场：公司简介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Agilent Technologies Inc.
• Nitto Denko Avecia Inc.
• Alnylam Pharmaceuticals Inc.
• Maravai Life Sciences
• LGC Limited
• Ionis Pharmaceuticals Inc.
• GenScript Inc.
• Ajinomoto Bio-Pharma Services
• Sarepta Therapeutics Inc.
• Integrated DNA Technologies Inc.
• Twist Bioscience Corporation
• Eurogentec SA
• Kaneka Eurogentec SA
• Biocomma Limited
• Bio-Synthesis Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029 年寡核苷酸合成市场：提供新机会的国家
• 2029 年寡核苷酸合成市场：细分领域带来新机会
• 寡核苷酸合成市场2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Oligonucleotide synthesis refers to the chemical process of linking nucleotides in a precise sequence, resulting in the formation of a desired product. This method is widely utilized in modern laboratory practices, providing a rapid and cost-effective means to obtain customized oligonucleotides with specific sequences.

There are two primary types of oligonucleotide synthesis, custom oligos and predesigned oligos. Custom oligos are produced through solid-phase chemical synthesis, where the nucleic acids A, T, C, and G are sequentially added to create a chain of nucleotides. The range of products involved in this process includes oligonucleotides, reagents, equipment, services, purification, and modification. These products find applications in various fields, such as therapeutic applications, research applications, and diagnostic applications. Oligonucleotide synthesis is a versatile tool that plays a crucial role in creating tailored genetic sequences for diverse purposes in the scientific and medical communities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The oligonucleotide synthesis market research report is one of a series of new reports from The Business Research Company that provides oligonucleotide synthesis market statistics, including oligonucleotide synthesis industry global market size, regional shares, competitors with a oligonucleotide synthesis market share, detailed oligonucleotide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the oligonucleotide synthesis industry. This oligonucleotide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oligonucleotide synthesis market size has grown rapidly in recent years. It will grow from $10.33 billion in 2024 to $11.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to growth in biomedical research advancements, therapeutic development, biotechnology innovations, genomic studies, and increasing DNA technologies.

The oligonucleotide synthesis market size is expected to see rapid growth in the next few years. It will grow to $22.2 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to emerging diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, nanotechnology applications, and advancements in gene editing. Major trends in the forecast period include targeted drug development, innovative delivery systems, automated synthesis, CRISPR-cas technology, and next-generation sequencing (NGS).

The forecast of 16.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. biotech research by increasing costs for phosphoramidite reagents and Deoxyribonucleic acid(DNA) synthesizers imported from Japan and Switzerland, potentially slowing drug development and raising preclinical lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The projected growth in the oligonucleotide synthesis market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, are a global health concern. Oligonucleotides play a crucial role in addressing chronic diseases by acting on gene expression through various mechanisms. They can target mRNA, pre-mRNA, or non-coding RNA to modulate splicing events, induce degradation, or interfere with protein translation. For instance, the global prevalence of diabetes is projected to increase by 12.2% in 2045, reaching 536.6 million individuals in the 20-79 age group, as reported by the International Diabetes Federation in January 2022. Additionally, chronic diseases, including cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, contribute to a significant percentage (74%) of global non-communicable disease-related deaths, with 41 million deaths annually, according to the World Health Organization in September 2022. This rising prevalence of chronic and rare diseases is a key driver fueling the growth of the oligonucleotide synthesis market.

The increasing demand for personalized medicine is expected to contribute to the market's growth. Personalized medicine, also known as precision medicine, leverages an individual's genetic and molecular profile to tailor prevention and treatment strategies. Oligonucleotide synthesis plays a vital role in developing precision medicines by providing small-molecule drugs composed of synthetically modified RNA or DNA strands that target specific cellular processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines on the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The increasing demand for personalized medicine is thus identified as a significant driver for the oligonucleotide synthesis market's growth.

Product innovation is a significant trend gaining traction in the oligonucleotide synthesis market. Key companies are focusing on developing innovative products to maintain their competitive edge in the market. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based manufacturer of complex DNA, introduced Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA delivers clonal, sequence-perfect DNA up to 600 base pairs in length, removing the need for assembly and providing unmatched accuracy for complex synthetic biology projects. This product guarantees error-free, ready-to-use DNA sequences, making it a dependable option for researchers. Ansa DNA Fragments offers sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, designed for various research applications. Through its innovative enzymatic synthesis process, Ansa consistently produces complex DNA constructs, including repeats and secondary structures, with high precision.

Major companies in the oligonucleotide synthesis market are focusing on introducing novel synthesis techniques, such as de novo synthesis, to gain a competitive edge. In March 2023, Ansa Biotechnologies, a U.S.-based biotechnology company, achieved a significant milestone by successfully de novo synthesizing the longest oligonucleotide in the world, comprising 1005 bases. This sequence encodes a crucial part of an Adeno-Associated Virus (AAV) vector used in gene therapy development. Overcoming challenges related to strong secondary structures and high GC content, this achievement allows for the direct synthesis of gene-length sequences, impacting the fields of genetic engineering and biotechnology.

In June 2024, GSK plc, a UK-based pharmaceutical company, acquired Elsie Biotechnologies for $50 million. This acquisition enables GSK to fully incorporate Elsie's technologies for oligonucleotide discovery, synthesis, and delivery into its research and development framework. This integration is anticipated to bolster GSK's current capabilities in creating oligonucleotide-based medicines. Elsie Biotechnologies is a US-based firm specializing in oligonucleotide therapeutics.

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oligonucleotide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oligonucleotide synthesis market consists of revenues earned by entities by providing non-coding RNA inhibition, splicing modulation, gene activation, and programmed gene editing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The oligonucleotide synthesis market also includes sales of RNAi oligonucleotides, antisense oligonucleotides, condensation activators, sulphur-transfer reagents, and deprotection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oligonucleotide Synthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oligonucleotide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oligonucleotide synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oligonucleotide synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Custom Oligos; Predesigned Oligos
• 2) By Product Type: Oligonucleotides; Reagents; Equipment; Services; Purification; Modification
• 3) By Application: Therapeutic Applications; Research Applications; Diagnostic Applications
• Subsegments:
• 1) By Custom Oligos: Long Oligonucleotides; Short Oligonucleotides; Modified Oligonucleotides
• 2) By Predesigned Oligos: Gene-Specific Oligos; Probe Oligos; Primers For PCR And RT-PCR
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Nitto Denko Avecia Inc.; Alnylam Pharmaceuticals Inc.; Maravai Life Sciences; LGC Limited; Ionis Pharmaceuticals Inc.; GenScript Inc.; Ajinomoto Bio-Pharma Services; Sarepta Therapeutics Inc.; Integrated DNA Technologies Inc.; Twist Bioscience Corporation; Eurogentec SA; Kaneka Eurogentec S.A.; Biocomma Limited; Bio-Synthesis Inc.; TriLink BioTechnologies Incorporated; Generi Biotech s.r.o.; ATDBio Ltd.; BioAutomation Corporation; Biolegio B.V.; Dharmacon Research Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oligonucleotide Synthesis Market Characteristics

3. Oligonucleotide Synthesis Market Trends And Strategies

4. Oligonucleotide Synthesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Oligonucleotide Synthesis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oligonucleotide Synthesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oligonucleotide Synthesis Market Growth Rate Analysis
• 5.4. Global Oligonucleotide Synthesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oligonucleotide Synthesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oligonucleotide Synthesis Total Addressable Market (TAM)

6. Oligonucleotide Synthesis Market Segmentation

• 6.1. Global Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom Oligos
• Predesigned Oligos
• 6.2. Global Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oligonucleotides
• Reagents
• Equipment
• Services
• Purification
• Modification
• 6.3. Global Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Applications
• Research Applications
• Diagnostic Applications
• 6.4. Global Oligonucleotide Synthesis Market, Sub-Segmentation Of Custom Oligos, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long Oligonucleotides
• Short Oligonucleotides
• Modified Oligonucleotides
• 6.5. Global Oligonucleotide Synthesis Market, Sub-Segmentation Of Predesigned Oligos, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene-Specific Oligos
• Probe Oligos
• Primers For PCR And RT-PCR

7. Oligonucleotide Synthesis Market Regional And Country Analysis

• 7.1. Global Oligonucleotide Synthesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oligonucleotide Synthesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oligonucleotide Synthesis Market

• 8.1. Asia-Pacific Oligonucleotide Synthesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oligonucleotide Synthesis Market

• 9.1. China Oligonucleotide Synthesis Market Overview
• 9.2. China Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oligonucleotide Synthesis Market

• 10.1. India Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oligonucleotide Synthesis Market

• 11.1. Japan Oligonucleotide Synthesis Market Overview
• 11.2. Japan Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oligonucleotide Synthesis Market

• 12.1. Australia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oligonucleotide Synthesis Market

• 13.1. Indonesia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oligonucleotide Synthesis Market

• 14.1. South Korea Oligonucleotide Synthesis Market Overview
• 14.2. South Korea Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oligonucleotide Synthesis Market

• 15.1. Western Europe Oligonucleotide Synthesis Market Overview
• 15.2. Western Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oligonucleotide Synthesis Market

• 16.1. UK Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oligonucleotide Synthesis Market

• 17.1. Germany Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oligonucleotide Synthesis Market

• 18.1. France Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oligonucleotide Synthesis Market

• 19.1. Italy Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oligonucleotide Synthesis Market

• 20.1. Spain Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oligonucleotide Synthesis Market

• 21.1. Eastern Europe Oligonucleotide Synthesis Market Overview
• 21.2. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oligonucleotide Synthesis Market

• 22.1. Russia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oligonucleotide Synthesis Market

• 23.1. North America Oligonucleotide Synthesis Market Overview
• 23.2. North America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oligonucleotide Synthesis Market

• 24.1. USA Oligonucleotide Synthesis Market Overview
• 24.2. USA Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oligonucleotide Synthesis Market

• 25.1. Canada Oligonucleotide Synthesis Market Overview
• 25.2. Canada Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oligonucleotide Synthesis Market

• 26.1. South America Oligonucleotide Synthesis Market Overview
• 26.2. South America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oligonucleotide Synthesis Market

• 27.1. Brazil Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oligonucleotide Synthesis Market

• 28.1. Middle East Oligonucleotide Synthesis Market Overview
• 28.2. Middle East Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oligonucleotide Synthesis Market

• 29.1. Africa Oligonucleotide Synthesis Market Overview
• 29.2. Africa Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oligonucleotide Synthesis Market Competitive Landscape And Company Profiles

• 30.1. Oligonucleotide Synthesis Market Competitive Landscape
• 30.2. Oligonucleotide Synthesis Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Oligonucleotide Synthesis Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Nitto Denko Avecia Inc.
• 31.3. Alnylam Pharmaceuticals Inc.
• 31.4. Maravai Life Sciences
• 31.5. LGC Limited
• 31.6. Ionis Pharmaceuticals Inc.
• 31.7. GenScript Inc.
• 31.8. Ajinomoto Bio-Pharma Services
• 31.9. Sarepta Therapeutics Inc.
• 31.10. Integrated DNA Technologies Inc.
• 31.11. Twist Bioscience Corporation
• 31.12. Eurogentec SA
• 31.13. Kaneka Eurogentec S.A.
• 31.14. Biocomma Limited
• 31.15. Bio-Synthesis Inc.

32. Global Oligonucleotide Synthesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oligonucleotide Synthesis Market

34. Recent Developments In The Oligonucleotide Synthesis Market

35. Oligonucleotide Synthesis Market High Potential Countries, Segments and Strategies

• 35.1 Oligonucleotide Synthesis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oligonucleotide Synthesis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oligonucleotide Synthesis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer